STELARA

STELARA

STELARA

Ustekinumab

45 mg/0.5 ml and 90 mg/1 ml vial.

JANSSEN Pharmaceutical

Medical Use

Stelara (ustekinumab) is a medication that acts as an antagonist to interleukin-12 and -23. It is FDA-approved and used to treat several conditions:

  • -Moderate to severe plaque psoriasis (Ps): Suitable for patients who are candidates for phototherapy or systemic therapy.
  • -Active psoriatic arthritis (PsA): Can be used alone or in combination with methotrexate.
  • -Moderately to severely active Crohn’s disease (CD): For patients who have not responded to or cannot tolerate immunomodulators or corticosteroids, and either have not failed a tumor necrosis factor (TNF) blocker or have failed or cannot tolerate one or more TNF blockers.